Springe direkt zu Inhalt

Publikationen

Zdrazil, B., Schwanke, A., Schmitz, B., Schäfer-Korting, M. and Höltje, H. D. (2011) Molecular modelling studies of new potential human DNA polymerase alpha inhibitors. J Enzyme Inhib Med Chem, 26, 270-279.

Schlupp, P., Blaschke, T., Kramer, K. D., Höltje, H. D., Mehnert, W. and Schäfer-Korting, M. (2011) Drug Release and Skin Penetration from Solid Lipid Nanoparticles and a Base Cream: A Systematic Approach from a Comparison of Three Glucocorticoids. Skin Pharmacol Physiol, 24, 199-209.

Semlin, L., Schäfer-Korting, M., Borelli, C. and Korting, H. C. (2011) In vitro models for human skin disease. Drug Discov Today, 16, 132-139. J. Sendzik, M. Shakibaei, M. Schäfer-Korting, H. Lode, and R. Stahlmann. Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents. 35:366-374 (2010).

M. Schäfer-Korting, M. Höltje, H.C. Korting, and H.D. Höltje. Innovative agents for actinic keratosis and nanocarriers enhancing skin penetration. Skin Pharmacol Physiol. 23:6-14 (2010). S. Küchler, N.B. Wolf, S. Heilmann, G. Weindl, J. Helfmann, M.M. Yahya, C. Stein, and M. Schäfer-Korting. 3D-Wound healing model: Influence of morphine and solid lipid nanoparticles. J Biotechnol. DOI: S0168-1656(10)00028-3 [pii] (2010).

S. Küchler, W. Herrmann, G. Panek-Minkin, T. Blaschke, C. Zoschke, K.D. Kramer, R. Bittl, and M. Schäfer-Korting. SLN for topical application in skin diseases-Characterization of drug-carrier and carrier-target interactions. Int J Pharm. DOI: S0378-5173(10)00099-2 [pii] (2010).

H.C. Korting and M. Schäfer-Korting. Carriers in the topical treatment of skin disease. Handb Exp Pharmacol:435-468 (2010).

M. Höltje, A. Richartz, B. Zdrazil, A. Schwanke, B. Dugovic, C. Murruzzu, H.U. Reissig, H.C. Korting, B. Kleuser, H.D. Höltje, and M. Schäfer-Korting. Human polymerase alpha inhibitors for skin tumors. Part 2. Modeling, synthesis and influence on normal and transformed keratinocytes of new thymidine and purine derivatives. J Enzyme Inhib Med Chem. 25:250-265 (2010).

K. Ackermann, S.L. Borgia, H.C. Korting, K.R. Mewes, and M. Schafer-Korting. The Phenion full-thickness skin model for percutaneous absorption testing. Skin Pharmacol Physiol. 23:105-112 (2010).

S. Küchler, M. Abdel-Mottaleb, A. Lamprecht, M.R. Radowski, R. Haag, and M. Schäfer-Korting. Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int J Pharm. 377:169-172 (2009).